Stiftung Charité offers a wide range of funding programs to attract fascinating personalities and renowned scientists and innovators from abroad to the life and medical sciences in Berlin—permanent recruitings as well as temporary engagements of guest scientists. With the BIH Visiting Professors, leading scientists from abroad or from other locations in Germany are recruited for guest stays at Charité – Universitätsmedizin Berlin (Charité), Berlin Institute of Health (BIH) (integrated into Charité since January 2021), and Max Delbrueck Center for Molecular Medicine (MDC) in order to give important impulses for the academic landscape and the innovation ecosystem in Berlin by sharing their experience, knowledge, and scientific and technological ideas. Stiftung Charité thus contributes to strengthening the life and medical sciences in Berlin and to international and national collaborations.
Visiting Professors are leading scientists in their specific field within the life and medical sciences in the public or private sector1 who come to Berlin for temporary activities at Charité, BIH and MDC. Their work stays are not designed to conduct a specific scientific project but to advance a recent project or to develop a completely new research and development program through cooperation between the host at Charité, BIH or MDC, the Visiting Professor, and possibly further partners, or to help the host by mentoring a single junior scientist. Visiting Professorships stimulate longer-term collaborative projects between the home institution of the Visiting Professors and Charité, BIH or MDC, and thus strategically extend the collaborative network of the life and medical sciences in Berlin.
Stiftung Charité supports Visiting Professors with funds from its Private Excellence Initiative Johanna Quandt.
1 oriented on „R4“ career level in accordance with the Euoropean Commission´s definition. Cf. European Commission: Towards a European Framework for Research Careers. Brüssel 2011. Hyperlink
Funding is provided for work stays of leading scientists for a total duration of three to nine months. The period can be divided into several work stays with great flexibility as long as it is appropriate for the project. It is possible to apply for one guest stay of nine months as well as for several single stays summing up to a total duration of at least three months. A single guest stay should usually not be shorter than one week and the period between the first and the last guest stay should usually not exceed two years. Funding totals up to 15,000.00 Euro per month (or part thereof) of the total duration.
The funding period has to end on December 31, 2024 the latest, and it cannot exceed an overall period of 24 months. An extension of the funding period beyond December 31, 2024 will not be possible.
A renewal of the funding cannot be applied for.
The visiting scientists may hold the title “Visiting Professor, funded by Stiftung Charité” for the duration of their work stay and beyond. In addition, if the respective conditions are met, the Visiting Professors are to be integrated in Charité as Gastprofessorinnen and Gastprofessoren in accordance with the state higher education regulations.
For a Visiting Professor, her or his own remuneration of up to 10,000.00 Euro per month (or part thereof) during the period of the stay can be applied for. In addition, material and personnel resources up to a level of 5,000.00 Euro per month during the period of the stay can be applied for, especially to cover the travel costs of the Visiting Professor (if necessary also for next of kin accompanying her or him). In justified cases, the funding for the remuneration of the Visiting Professor can also be reallocated to fund material resources or personnel resources for scientific staff, provided that the work stays of the Visiting Professor can be guaranteed in other ways.
The host at Charité, BIH or MDC guarantees the provision of a suitable workplace including the necessary infrastructure, material, and equipment from her or his own funds.
Stiftung Charité funding is provided as a lump sum totaling up to 15,000.00 Euro per month respectively to Charité, BIH or MDC. The host at Charité, BIH or MDC arranges the details of the remuneration procedure with the Visiting Professor and her or his home institution. A further payment of existing remuneration to the Visiting Professor by the home institution and payment of a compensation to the home institution or leave of absence of the Visiting Professor at the home institution and payment of a remuneration to the Visiting Professor (e.g. royalty or stipend) would be conceivable. Travel funds must be used in accordance with the rules and regulations of the host institution. No contractual relations are entered by Stiftung Charité and the Visiting Professor. All necessary arrangements are to be made directly between the host at Charité, BIH or MDC on the one hand and the Visiting Professor on the other.
Proposals are submitted by the host at Charité, BIH or MDC. Hosts can be either scientists at Charité or BIH heading a CharitéCenter, an institute or a clinic, or scientists at MDC heading a research area or a research team. The proposals are submitted respectively for the nominated Visiting Professor and are drawn up jointly with her or him. The nominated Visiting Professor has to be a leading scientist2 in the respective field within the life and medical sciences. She or he has to be able to demonstrate relevant scientific experiences and achievements. In addition to common achievements in research and teaching, performance in knowledge and technology transfer as well as provision of scientific infrastructure are given equal consideration. The nominated Visiting Professor can be employed in the public or private sector in Germany and abroad or can be retired.
2 oriented on „R4“ career level in accordance with the Euoropean Commission´s definition. Cf. European Commission: Towards a European Framework for Research Careers. Brüssel 2011. Hyperlink
The proposal should demonstrate that the nominated Visiting Professor holds the qualifications required for a senior scientist position. Achievements in research, teaching, knowledge and technology transfer, and infrastructure provision are equally taken into account.
Furthermore, the proposal has to explain what scientific project the host and the nominated Visiting Professor seek to pursue during the work stays. Projects eligible for funding have to pursue one of the following aims:
- Consultancy and support activities to advance a recent research and development program,
- Concept and initiation of a new larger cooperative project designed for a period of several years, or
- Mentoring and scientific supervision of a single junior scientist in the host institution with regard to specific projects which are promising for the supervised scientist.
Independently from the aim, it is expected that at the end of the funding by Stiftung Charité, a proposal to acquire competitive third-party funding, e.g. from the German Research Foundation (DFG) or the European Research Council, is made and ready for submission. According to its specific aim, this proposal following the possible funding by Stiftung Charité should be submitted by (a) the host institution only, (b) the host institution, the Visiting Professor, and partners collaboratively, or (c) the supervised junior researcher in the host institution.
For this reason, the project description in the application should clarify what added value is generated for the respective host institution at Charité, BIH or MDC and their national and international cooperation network, and how cooperation between the Visiting Professor, her/his home institution and the host institution is to be continued throughout the length of the work stay and beyond. The project can also be explicitly used to establish new collaborative relations for Charité, BIH or MDC.
The proposal is drawn up using the proposal forms provided by Stiftung Charité. By submitting this application I confirm that I took note of data protection information (Datenschutzhinweis) of Stiftung Charité.
When applying, and in the case of funding being approved, the Rules of Safeguarding Good Scientific Practice of the Deutsche Forschungsgemeinschaft as well as the ethical principles of the European Union’s Framework Programme for Research and Innovation (Horizon 2020), including the European Code of Conduct for Research Integrity, are to be observed. In addition, the Stiftung Charité approval principles apply.
Applications have to be submitted to Stiftung Charité. Stiftung Charité evaluates the applications formally. If the application passes the formal evaluation, a respective statement is obtained from the BIH Board of Directors. Additionally, a selection committee appointed by Stiftung Charité gives funding recommendations considering the statements mentioned above. The Academic Advisory Council of the Private Excellence Initiative Johanna Quandt takes the final funding decision.
- Associate Professor Marcus Friedrich, New York State Department of Health, Office of Quality and Patient Safety, Hosts: Professorin Claudia Spies (Charité), Professor Felix Balzer (Charité), Professor Roland Eils (BIH), Professorin Petra Gastmeier (Charité), Research Project: „Establishment of the Charité as a national leader for machine-learning sepsis innovation and comprehensive quality data collection and management”
- PhD Anita Bandrowski, University of California at San Diego, Neurosciences, Hosts: Professor Ulrich Dirnagl (BIH), PhD Tracey Weibssgerber (BIH), Research Project: „Automated tool screening of manuscripts for rigor and reproducibility criteria: a collaborative approach”
- Professor Nir Friedman, The Hebrew University of Jerusalem, School of Computer Science and Engineering, Hosts: Professor Nikolaus Rajewsky (MDC), Professorin Angelika Eggert (Charité), Professor Kai-Uwe Eckardt (Charité), Research Project: „Chromatin immunoprecipitation and sequencing of cell‐free nucleosomes (cfChIP‐seq) to identify biomarkers in kidney disease and cancer”
- Professor Daniel Le Grange, University of California at San Francisco, Department of Psychiatry and Behavioral Sciences, Host: Professor Chrisoph U. Correll (Charité), Research Project: „Implementation of Family based treatment for Youth with anorexia nervosa in Berlin”
- MD, PhD Gertraud Maskarinec, University of Hawaii, Cancer Center, Hosts: Professor Tobias Pischon (MDC), Prof. Dr. Joachim Spranger (Charité), Research Project: „Diet Quality, Body Fat Distribution, and Type 2 Diabetes - Translating Knowledge from Population Based Studies into Prevention Strategies”
- Professor Per-Olof Berggren, Karolinska Institutet, Department of Molecular Medicine and Surgery, The Rolf Luft Research Center, Host: Professor Joachim Spranger (Charité), Forschungsprojekt: "Intraocular Islet/Islet-Organoid Transplantation for monitoring diabetes progression and treatment"
- Professor Christine Knabe-Ducheyne, Philipps-Universität Marburg, Department of Experimental Orofacial Medicine, Host: Professor Max Heiland (Charité), Forschungsprojekt: "Vascularized tissue engineered 3D-printed ceramic bone grafts for reconstruction of mandibular segmental defects"
- Professor Robert Schwabe, Columbia University, Host: Professor Frank Tacke (Charité), Research project: "Understanding and targeting of hepatic stellate cells in non-alcoholic steatohepatitis by single cell-based systems biology"
- Professor Hans-Georg Kuhn, University of Gothenburg, Department of Neuroscience and Physiology Institute for Clinical Neuroscience, Host: Professor Tobias Kurth (Charité), Research project: "From Beyond the Bedside back to the Bench: How population-based methods can inform basic science practice"
- Professor Sevil Yasar, Johns Hopkins University, Division of Geriatric Medicine& Gerontology, Host: Professor Adelheid Kuhlmey (Charité), Research project: "Statin use in older community dwelling patients with dementia: what do we know and should we change practice"
- Professor Vasan Ramachandran, Boston University School of Medicine, Department of Medicine, Section of Preventive Medicine & Epidemiology Host: Professor Burkert Pieske (Charité), Research project: "Developing a strategic concept to establish the Berlin Longterm Observation of Vascular Events (BeLOVE) cohort as a translational keystone for cardiovascular research at Charité and BIH"
- Prof. Giulio Cossu, University of Manchester, Faculty of Biology, Medicine and Health, Host: Professorin Simone Spuler (Charité/MDC), Research project: "Translation of muscle stem cells from research into a new ATMP product for clinical use"
- Prof. Konrad Reinhart, Universitätsklinikum Jena, Host: Professorin Claudia Spies (Charité), Research project: "Konzeptskizze für den Aufbau eines Sepsis-Schwerpunkts mit einem WHO Sepsis Collaborating Centers an der Charité/BIH"
- Prof. Richard Koche, Memorial Sloan Kettering Cancer Center, Host: Professorin Angelika Eggert (Charité), Research project: "DNA circularization as a mutagenic process in pediatric cancer development"
- Prof. Ray Dolan, University College London, Host: Professor Andreas Heinz (Charité), Research project: "Smartphone-based computational phenotyping in psychiatric disorders"
- Prof. Falk Müller-Riemenschneider, National University of Singapore, Host: Professor Roland Eils (BIH), Research project: "From continuous real-life monitoring to personalized digital interventions"
- Prof. Udo Hoffmann, Massachusetts General Hospital, Harvard University/Medical School, Host: Professor Bernd Hamm (Charité), Research project: "The Power of Medical Imaging – Towards Improved Clinical Outcomes through Data Sharing of Randomized Imaging Trials"
- Prof. Dr. Hans Lehrach, Max Planck Institute for Molecular Genetics, Host: Dr. Rolf Zettl (BIH), Research project: "DIGITWINS: Digital Twins for Better Health"
- Prof. Dr. Peter Hildebrand, Universität Leipzig, Host: Prof. Dr. Axel Radlach Pries (Charité), Research project: "Viewing and sharing time resolved motions of G protein coupled receptors on the web"
- Prof. Dr. Guiseppe Macino, La Sapienza University of Rome, Host: Prof. Dr. Nikolaus Rajewsky (MDC), Research project: "Single Cell Genetics and Epigenetics of Patient Derived Tumor and Brain Organoids"
- Prof. Dr. Konrad Reinhart, Universitäts-klinikum Jena, Host: Prof. Dr. Claudia Spies (Charité), Research project: "Konzeptentwicklung und Anbahnung eines Comprehensive Sepsis Centers an der Charité"
- Prof. Dr. Heiko Becher, Universitäts klinikum Hamburg-Eppendorf, Host: Prof. Dr. Geraldine Rauch (Charité), Research project: "eSTablishing clinical EPidemiology as a key competence for fUture research Projects (STEP UP)"
- Prof. Dr. Hans Lehrach, Max Planck Institute of Molecular Genetics Berlin, Host: Prof. Dr. Erwin Böttinger (Berlin Institute of Health), Research project: “The Future of Healthcare"
- Prof. Dr. Peter Van Endert, Université Paris Descartes, Host: Prof. Dr. Peter Kloetzel (Charité), Research project: “Optimising MHC Class I (Cross-)Presentation to promote tumor rejection by CD8+ T Cells"
- Prof. Dr. Lu Chen, Stanford University, Host: Prof. Dr. Christian Rosenmund (Charité), Research project: “How do plastic changes at synapses in a circuit enable learning, encode memory, and drive behavior?"
- Prof. Dr. Robert Frigg, Swiss Federal Institute of Technology in Zurich, Host: Dr. Rolf Zettl (BIH), Research project: “Förderung von Medizintechnischen Lösungen und deren Translation in Medizinprodukte"
- Prof. Dr. Sylvia Thun, Hochschule Niederrhein, Gastgeber: Axel Radlach Pries (Charité), Forschungsprojekt: “Einrichtung einer eHealth und Interoperability Core Unit"
- Prof. Dr. Hannah Monyer, Medical Faculty at the University of Heidelberg and DKFZ, Host: Prof. Dr. Dietmar Schmitz (Charité), Research project: “Inhibition in the context of cortical columnar organization"
- Prof. Dr. Steffen Gay, University Hospital Zurich, Host: Prof. Dr. Gerd-Rüdiger Burmester (Charité), Research project: “Development of Novel Biomarkers for the Detection of Response to anti-rheumatic drugs"
- Dr. Michael Potente, Max Planck Institute for Heart and Lung Research, Host: Prof. Dr. Holger Gerhardt (MDC), Research project: “Mechanisms of vessel size regulation - role of YAP/TAZ signaling"